CRISPR gene therapy increases haemoglobin and fetal haemoglobin in sickle cell disease, reducing vaso occlusive events in ...

Stuart Orkin and Swee Lay Thein shared a Breakthrough Prize in Life Sciences for their research on genetic causes of sickle ...

CRISPR Therapeutics proved the strength of its technology a couple of years ago when it won approval for its first product.

Charles Gersbach and his colleagues are pursuing promising CRISPR technologies focused on controlling gene activity rather ...

In this GEN webinar, Tilmann Buerckstuemmer, PhD, CSO at Myllia Biotechnology will show how high-throughput pooled CRISPR ...

From targeting stubborn tumor genes like PIK3CA to designing ultra-precise editors like ThermoCas9, CRISPR is reshaping the fight against cancer. Researchers are now engineering cells that resist drug ...

CRSP posts a wider Q1 loss and revenues miss, pressuring shares, even as Casgevy sales grow and cash reserves strengthen from recent financing.

Researchers have used modified CRISPR to silence the extra chromosome 21 in Down syndrome cells, showing promising ...